Goldman Sachs Group Inc Generation Bio Co. Call Options Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GBIO
# of Institutions
39Shares Held
22.4MCall Options Held
116KPut Options Held
0-
Price T Rowe Associates Inc Baltimore, MD8.46MShares$46.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$18.1 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.94MShares$10.7 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.06MShares$5.84 Million0.0% of portfolio
-
Yiheng Capital Management, L.P. San Francisco, CA1.06MShares$5.8 Million0.03% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $325M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...